With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.879896-50-1,2-(4-Methylpiperazin-1-ylmethyl)benzylamine,as a common compound, the synthetic route is as follows.,879896-50-1
Example 111 lambda/-Methoxy-4-methyl-3-[3-[[[2-[(4-methyl-1-piperazinyl)methyl]phenyl]methyl]amino]- 2-oxo-1(2H)-pyrazinyl]-benzamideTo a stirred solution of 3-(3,5-dibromo-2-oxo-2H-pyrazin-1-yl)-4-methyl-benzoic acid, methyl ester (Example 1 b, 0.1 g) in tetrahydrofuran (2 ml.) in a microwave vial was added triethylamine (250 mul_) and 2-[(4-methyl-1-piperazinyl)methyl]-benzenemethanamine (90 mg). The reaction was stirred overnight before the addition of O-methylhydroxylamine hydrochloride (83 mg) and cyclopentylmagnesium bromide (2M in diethyl ether, 2 ml.) dropwise. After stirring for 60 minutes, ethanol (2 ml.) was added followed by the addition of ammonium formate (0.4 g) and 10% palladium on carbon (40 mg). The reaction mixture was heated within a microwave for 30 minutes at 100C before being cooled to room temperature, filtered and washed with ethanol. The filtrate was concentrated in vacuo.
The synthetic route of 879896-50-1 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; ASTRAZENECA AB; ASTRAZENECA UK LIMITED; WO2009/1132; (2008); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics